Emergency Access to Insulin Act of 2023

The Emergency Access to Insulin Act of 2023 creates a federal grant program for states, tribes, and tribal organizations to help uninsured and underinsured individuals obtain insulin at no cost. Under the program, states would issue insulin cards that allow individuals to get insulin from participating pharmacies without cost, with states required to provide matching funds (1:3 federal to state ratio). The bill also imposes an excise tax on insulin manufacturers for price increases that exceed the inflation rate, with tax rates increasing based on the size of the price spike. The program would be available for five years, with states required to report on program effectiveness annually to Congress.